Literature DB >> 14523593

Medical management of hypercalcemia.

S H Ralston1, R Coleman, W D Fraser, S J Gallagher, D J Hosking, J S Iqbal, E McCloskey, D Sampson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14523593     DOI： 10.1007/s00223-001-1135-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  6 in total

1.  Oral calcitonin.

Authors:  Michael J Maricic
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 2.  Salmon calcitonin: a review of current and future therapeutic indications.

Authors:  C H Chesnut; M Azria; S Silverman; M Engelhardt; M Olson; L Mindeholm
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

3.  Administration of bisphosphonate for hypercalcemia associated with oral cancer.

Authors:  Kojiro Onizawa; Hiroshi Yoshida
Journal:  Head Face Med       Date:  2006-04-10       Impact factor: 2.151

4.  Severe hypercalcemia caused by parathyroid hormone in a rectal cancer metastasis: a case report.

Authors:  Vegard Heimly Brun; Erik Knutsen; Helge Stenvold; Hanne Halvorsen
Journal:  BMC Endocr Disord       Date:  2021-01-07       Impact factor: 2.763

5.  Calcium Alkali Syndrome Treated With Hemodialysis.

Authors:  Barbara M Parker
Journal:  Cureus       Date:  2021-03-07

6.  Local application of ibandronate/gelatin sponge improves osteotomy healing in rabbits.

Authors:  Zongyou Yang; Wei Chen; Zhidao Xia; Yueju Liu; Shaun Peggrem; Tao Geng; Zhaoxu Yang; Han Li; Bin Xu; Chi Zhang; James T Triffitt; Yingze Zhang
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.